These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

712 related items for PubMed ID: 30390677

  • 1. MYO18B promotes hepatocellular carcinoma progression by activating PI3K/AKT/mTOR signaling pathway.
    Zhang Z, Zhu J, Huang Y, Li W, Cheng H.
    Diagn Pathol; 2018 Nov 03; 13(1):85. PubMed ID: 30390677
    [Abstract] [Full Text] [Related]

  • 2. Eukaryotic elongation factor-1α 2 knockdown inhibits hepatocarcinogenesis by suppressing PI3K/Akt/NF-κB signaling.
    Qiu FN, Huang Y, Chen DY, Li F, Wu YA, Wu WB, Huang XL.
    World J Gastroenterol; 2016 Apr 28; 22(16):4226-37. PubMed ID: 27122673
    [Abstract] [Full Text] [Related]

  • 3. Activation of PI3K/AKT is involved in TINAG-mediated promotion of proliferation, invasion and migration of hepatocellular carcinoma.
    Zhang MH, Niu H, Li Z, Huo RT, Wang JM, Liu J.
    Cancer Biomark; 2018 Apr 28; 23(1):33-43. PubMed ID: 29991125
    [Abstract] [Full Text] [Related]

  • 4. SOCS5 inhibition induces autophagy to impair metastasis in hepatocellular carcinoma cells via the PI3K/Akt/mTOR pathway.
    Zhang M, Liu S, Chua MS, Li H, Luo D, Wang S, Zhang S, Han B, Sun C.
    Cell Death Dis; 2019 Aug 13; 10(8):612. PubMed ID: 31406106
    [Abstract] [Full Text] [Related]

  • 5. Alpha1-ACT Functions as a Tumour Suppressor in Hepatocellular Carcinoma by Inhibiting the PI3K/AKT/mTOR Signalling Pathway via Activation of PTEN.
    Zhu H, Liu Q, Tang J, Xie Y, Xu X, Huang R, Zhang Y, Jin K, Sun B.
    Cell Physiol Biochem; 2017 Aug 13; 41(6):2289-2306. PubMed ID: 28456796
    [Abstract] [Full Text] [Related]

  • 6. Down-regulation of LncRNA NR027113 inhibits cell proliferation and metastasis via PTEN/PI3K/AKT signaling pathway in hepatocellular carcinoma.
    Chen Z, Zhou ZY, He CC, Zhang JL, Wang J, Xiao ZY.
    Eur Rev Med Pharmacol Sci; 2018 Nov 13; 22(21):7222-7232. PubMed ID: 30468465
    [Abstract] [Full Text] [Related]

  • 7. CLCA4 inhibits cell proliferation and invasion of hepatocellular carcinoma by suppressing epithelial-mesenchymal transition via PI3K/AKT signaling.
    Liu Z, Chen M, Xie LK, Liu T, Zou ZW, Li Y, Chen P, Peng X, Ma C, Zhang WJ, Li PD.
    Aging (Albany NY); 2018 Oct 11; 10(10):2570-2584. PubMed ID: 30312171
    [Abstract] [Full Text] [Related]

  • 8. Overexpression of cancer susceptibility candidate 2 inhibited progression of hepatocellular carcinoma cells.
    Gao X, Du H, Zhang R, Li C, Wang H, Xuan Q, Liu D.
    J Cell Physiol; 2019 Jun 11; 234(6):9008-9018. PubMed ID: 30362539
    [Abstract] [Full Text] [Related]

  • 9. Long noncoding RNA-JPX predicts the poor prognosis of ovarian cancer patients and promotes tumor cell proliferation, invasion and migration by the PI3K/Akt/mTOR signaling pathway.
    Li J, Feng L, Tian C, Tang YL, Tang Y, Hu FQ.
    Eur Rev Med Pharmacol Sci; 2018 Dec 11; 22(23):8135-8144. PubMed ID: 30556851
    [Abstract] [Full Text] [Related]

  • 10. cPLA2α activates PI3K/AKT and inhibits Smad2/3 during epithelial-mesenchymal transition of hepatocellular carcinoma cells.
    Fu H, He Y, Qi L, Chen L, Luo Y, Chen L, Li Y, Zhang N, Guo H.
    Cancer Lett; 2017 Sep 10; 403():260-270. PubMed ID: 28649002
    [Abstract] [Full Text] [Related]

  • 11. HSCs-derived COMP drives hepatocellular carcinoma progression by activating MEK/ERK and PI3K/AKT signaling pathways.
    Li Q, Wang C, Wang Y, Sun L, Liu Z, Wang L, Song T, Yao Y, Liu Q, Tu K.
    J Exp Clin Cancer Res; 2018 Sep 19; 37(1):231. PubMed ID: 30231922
    [Abstract] [Full Text] [Related]

  • 12. LncRNA DCST1-AS1 accelerates the proliferation, metastasis and autophagy of hepatocellular carcinoma cell by AKT/mTOR signaling pathways.
    Li J, Zhai DS, Huang Q, Chen HL, Zhang Z, Tan QF.
    Eur Rev Med Pharmacol Sci; 2019 Jul 19; 23(14):6091-6104. PubMed ID: 31364110
    [Abstract] [Full Text] [Related]

  • 13. The long non-coding RNA PTTG3P promotes cell growth and metastasis via up-regulating PTTG1 and activating PI3K/AKT signaling in hepatocellular carcinoma.
    Huang JL, Cao SW, Ou QS, Yang B, Zheng SH, Tang J, Chen J, Hu YW, Zheng L, Wang Q.
    Mol Cancer; 2018 May 26; 17(1):93. PubMed ID: 29803224
    [Abstract] [Full Text] [Related]

  • 14. Small nucleolar RNA ACA11 promotes proliferation, migration and invasion in hepatocellular carcinoma by targeting the PI3K/AKT signaling pathway.
    Wu L, Zheng J, Chen P, Liu Q, Yuan Y.
    Biomed Pharmacother; 2017 Jun 26; 90():705-712. PubMed ID: 28419966
    [Abstract] [Full Text] [Related]

  • 15. HS-116, a novel phosphatidylinositol 3-kinase inhibitor induces apoptosis and suppresses angiogenesis of hepatocellular carcinoma through inhibition of the PI3K/AKT/mTOR pathway.
    Jung KH, Choi MJ, Hong S, Lee H, Hong SW, Zheng HM, Lee HS, Hong S, Hong SS.
    Cancer Lett; 2012 Mar 28; 316(2):187-95. PubMed ID: 22182943
    [Abstract] [Full Text] [Related]

  • 16. Upregulation of lncRNA FER1L4 suppresses the proliferation and migration of the hepatocellular carcinoma via regulating PI3K/AKT signal pathway.
    Wang X, Dong K, Jin Q, Ma Y, Yin S, Wang S.
    J Cell Biochem; 2019 Apr 28; 120(4):6781-6788. PubMed ID: 30382631
    [Abstract] [Full Text] [Related]

  • 17. miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway.
    Wang R, Yu Z, Chen F, Xu H, Shen S, Chen W, Chen L, Su Q, Zhang L, Bi J, Zeng W, Li W, Huang X, Wang Q.
    Biomed Pharmacother; 2018 Jul 28; 103():1632-1642. PubMed ID: 29864952
    [Abstract] [Full Text] [Related]

  • 18. SPAG5 interacts with CEP55 and exerts oncogenic activities via PI3K/AKT pathway in hepatocellular carcinoma.
    Yang YF, Zhang MF, Tian QH, Fu J, Yang X, Zhang CZ, Yang H.
    Mol Cancer; 2018 Aug 08; 17(1):117. PubMed ID: 30089483
    [Abstract] [Full Text] [Related]

  • 19. Ropivacaine suppresses tumor biological characteristics of human hepatocellular carcinoma via inhibiting IGF-1R/PI3K/AKT/mTOR signaling axis.
    Zhang R, Lian Y, Xie K, Cai Y, Pan Y, Zhu Y.
    Bioengineered; 2021 Dec 08; 12(2):9162-9173. PubMed ID: 34696683
    [Abstract] [Full Text] [Related]

  • 20. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.
    Wu WL, Wang WY, Yao WQ, Li GD.
    Int J Mol Med; 2015 Dec 08; 36(6):1713-9. PubMed ID: 26499886
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.